Article
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
The American journal of tropical medicine and hygiene - 1 Jun 2013
Zhang Peng, Gao Xiugong, Ishida Hiroshi, Amnuaysirikul Jack, Weina Peter J, Grogl Max, O'Neil Michael T, Li Qigui, Caridha Diana, Ohrt Colin, Hickman Mark, Magill Alan J, Ray Prabhati
Abstract excerpt
Anti-malarial 8-aminoquinolines drugs cause acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDD). Efforts to develop non-hemolytic 8-aminoquinolines have been severely limited caused by the lack of a predictive in vivo animal model of hemolytic potential that would allow screening of candidate compounds. This report describes a G6PDD mouse model with a phenotype closely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
